{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:30:10Z","timestamp":1773455410440,"version":"3.50.1"},"publisher-location":"Singapore","reference-count":62,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811057649","type":"print"},{"value":"9789811057656","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-981-10-5765-6_3","type":"book-chapter","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T09:09:35Z","timestamp":1508404175000},"page":"23-34","source":"Crossref","is-referenced-by-count":63,"title":["Human Papillomavirus-Related Cancers"],"prefix":"10.1007","author":[{"given":"Yanyun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congjian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,20]]},"reference":[{"key":"3_CR1","first-page":"3","volume":"97","author":"Humans IWGotEoCRt","year":"2008","unstructured":"Humans IWGotEoCRt (2008) IARC monographs on the evaluation of carcinogenic risks to humans. Volume 97. 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). IARC Monogr Eval Carcinog Risks Hum 97:3\u2013471","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"3_CR2","first-page":"1","volume":"63","author":"LE Markowitz","year":"2014","unstructured":"Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA Jr, Unger ER, Centers for Disease C, Prevention (2014) Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep: Morb Mortal Wkly Rep Recomm Rep 63:1\u201330","journal-title":"MMWR Recomm Rep: Morb Mortal Wkly Rep Recomm Rep"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/2229-516X.179027","volume":"6","author":"A Bansal","year":"2016","unstructured":"Bansal A, Singh MP, Rai B (2016) Human papillomavirus-associated cancers: a growing global problem. Int J Appl Basic Med Res 6:84\u201389","journal-title":"Int J Appl Basic Med Res"},{"key":"3_CR4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S Sanjose de","year":"2007","unstructured":"de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453\u2013459","journal-title":"Lancet Infect Dis"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ijc.27650","volume":"131","author":"M Arbyn","year":"2012","unstructured":"Arbyn M, de Sanjose S, Saraiya M, Sideri M, Palefsky J, Lacey C, Gillison M, Bruni L, Ronco G, Wentzensen N, Brotherton J, Qiao YL, Denny L, Bornstein J, Abramowitz L, Giuliano A, Tommasino M, Monsonego J (2012) EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer 131:1969\u20131982","journal-title":"Int J Cancer"},{"key":"3_CR6","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.pedn.2015.10.005","volume":"31","author":"K Valentino","year":"2016","unstructured":"Valentino K, Poronsky CB (2016) Human papillomavirus infection and vaccination. J Pediatr Nurs 31:e155\u2013e166","journal-title":"J Pediatr Nurs"},{"key":"3_CR7","first-page":"S2","volume":"108","author":"EJ Mayeaux Jr","year":"2008","unstructured":"Mayeaux EJ Jr (2008) Reducing the economic burden of HPV-related diseases. J Am Osteopath Assoc 108:S2\u2013S7","journal-title":"J Am Osteopath Assoc"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jinf.2012.10.024","volume":"66","author":"C Chelimo","year":"2013","unstructured":"Chelimo C, Wouldes TA, Cameron LD, Elwood JM (2013) Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J Infect 66:207\u2013217","journal-title":"J Infect"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202:1789\u20131799","journal-title":"J Infect Dis"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","volume":"297","author":"EF Dunne","year":"2007","unstructured":"Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE (2007) Prevalence of HPV infection among females in the United States. JAMA 297:813\u2013819","journal-title":"JAMA"},{"key":"3_CR11","first-page":"48","volume":"74","author":"PP Matkins","year":"2013","unstructured":"Matkins PP (2013) Sexually transmitted infections in adolescents. N C Med J 74:48\u201352","journal-title":"N C Med J"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.2741\/1971","volume":"11","author":"ZM Zheng","year":"2006","unstructured":"Zheng ZM, Baker CC (2006) Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci: J Virtual Libr 11:2286\u20132302","journal-title":"Front Biosci: J Virtual Libr"},{"issue":"Suppl 1","key":"3_CR13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","volume":"25","author":"J Doorbar","year":"2015","unstructured":"Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I (2015) Human papillomavirus molecular biology and disease association. Rev Med Virol 25(Suppl 1):2\u201323","journal-title":"Rev Med Virol"},{"key":"3_CR14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.7150\/ijbs.6.730","volume":"6","author":"ZM Zheng","year":"2010","unstructured":"Zheng ZM (2010) Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci 6:730\u2013755","journal-title":"Int J Biol Sci"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/sj.onc.1205214","volume":"21","author":"T Wiest","year":"2002","unstructured":"Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX (2002) Involvement of intact HPV16 E6\/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21:1510\u20131517","journal-title":"Oncogene"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1128\/JVI.71.3.2449-2456.1997","volume":"71","author":"M Evander","year":"1997","unstructured":"Evander M, Frazer IH, Payne E, Qi YM, Hengst K, McMillan NA (1997) Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol 71:2449\u20132456","journal-title":"J Virol"},{"key":"3_CR17","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1074\/jbc.274.9.5810","volume":"274","author":"JG Joyce","year":"1999","unstructured":"Joyce JG, Tung JS, Przysiecki CT, Cook JC, Lehman ED, Sands JA, Jansen KU, Keller PM (1999) The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem 274:5810\u20135822","journal-title":"J Biol Chem"},{"key":"3_CR18","first-page":"1209","volume":"82","author":"G Juckett","year":"2010","unstructured":"Juckett G, Hartman-Adams H (2010) Human papillomavirus: clinical manifestations and prevention. Am Fam Physician 82:1209\u20131213","journal-title":"Am Fam Physician"},{"key":"3_CR19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000356515","volume":"45","author":"H Ikenberg","year":"2014","unstructured":"Ikenberg H (2014) Laboratory diagnosis of human papillomavirus infection. Curr Probl Dermatol 45:166\u2013174","journal-title":"Curr Probl Dermatol"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/LGT.0b013e3182776320","volume":"17","author":"V Wiwanitkit","year":"2013","unstructured":"Wiwanitkit V (2013) Cervista HPV HR test kit in cervical cancer screening. J Low Genit Tract Dis 17:99","journal-title":"J Low Genit Tract Dis"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1309\/4DXEAFG2JXYF34N3","volume":"130","author":"LR Johnson","year":"2008","unstructured":"Johnson LR, Starkey CR, Palmer J, Taylor J, Stout S, Holt S, Hendren R, Bock B, Waibel E, Tyree G, Miller GC (2008) A comparison of two methods to determine the presence of high-risk HPV cervical infections. Am J Clin Pathol 130:401\u2013408","journal-title":"Am J Clin Pathol"},{"key":"3_CR22","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jmoldx.2013.04.002","volume":"15","author":"M Rebolj","year":"2013","unstructured":"Rebolj M, Preisler S, Ejegod DM, Bonde J, Rygaard C, Lynge E (2013) Prevalence of Human Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assay. J Mol Diagn: JMD 15:670\u2013677","journal-title":"J Mol Diagn: JMD"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","volume":"136","author":"TC Wright","year":"2015","unstructured":"Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL (2015) Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol 136:189\u2013197","journal-title":"Gynecol Oncol"},{"key":"3_CR24","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(11)61351-2","volume":"378","author":"MH Forouzanfar","year":"2011","unstructured":"Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (London, England) 378:1461\u20131484","journal-title":"Lancet (London, England)"},{"key":"3_CR25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319","journal-title":"J Pathol"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476","volume":"31","author":"M Schiffman","year":"2003","unstructured":"Schiffman M, Kjaer SK (2003) Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 31:14\u201319","journal-title":"J Natl Cancer Inst Monogr"},{"key":"3_CR27","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S Sanjose de","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menendez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez GI, Nowakowski AM, Bornstein J, Munoz N, Bosch FX (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11:1048\u20131056","journal-title":"Lancet Oncol"},{"key":"3_CR28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/341782","volume":"186","author":"AR Giuliano","year":"2002","unstructured":"Giuliano AR, Harris R, Sedjo RL, Baldwin S, Roe D, Papenfuss MR, Abrahamsen M, Inserra P, Olvera S, Hatch K (2002) Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women\u2019s Health Study. J Infect Dis 186:462\u2013469","journal-title":"J Infect Dis"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1158\/1078-0432.CCR-06-2881","volume":"13","author":"PE Castle","year":"2007","unstructured":"Castle PE, Dockter J, Giachetti C, Garcia FA, McCormick MK, Mitchell AL, Holladay EB, Kolk DP (2007) A cross-sectional study of a prototype carcinogenic human papillomavirus E6\/E7 messenger RNA assay for detection of cervical precancer and cancer. Clin Cancer Res: Off J Am Assoc Cancer Res 13:2599\u20132605","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"key":"3_CR30","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","volume":"97","author":"MJ Khan","year":"2005","unstructured":"Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M (2005) The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97:1072\u20131079","journal-title":"J Natl Cancer Inst"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.11222","volume":"106","author":"V Dalstein","year":"2003","unstructured":"Dalstein V, Riethmuller D, Pretet JL, Le Bail CK, Sautiere JL, Carbillet JP, Kantelip B, Schaal JP, Mougin C (2003) Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 106:396\u2013403","journal-title":"Int J Cancer"},{"key":"3_CR32","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0140-6736(00)02401-6","volume":"355","author":"AM Josefsson","year":"2000","unstructured":"Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Andersen PK, Melbye M, Adami HO, Gyllensten UB (2000) Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet (London, England) 355:2189\u20132193","journal-title":"Lancet (London, England)"},{"key":"3_CR33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/427032","volume":"40","author":"FB Lillo","year":"2005","unstructured":"Lillo FB, Lodini S, Ferrari D, Stayton C, Taccagni G, Galli L, Lazzarin A, Uberti-Foppa C (2005) Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection. Clin Infect Dis : Off Publ Infect Dis Soc Am 40:451\u2013457","journal-title":"Clin Infect Dis : Off Publ Infect Dis Soc Am"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","volume":"12","author":"AG Ostor","year":"1993","unstructured":"Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol: Off J Int Soc Gynecol Pathol 12:186\u2013192","journal-title":"Int J Gynecol Pathol: Off J Int Soc Gynecol Pathol"},{"key":"3_CR35","unstructured":"Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 90:1\u2013636"},{"key":"3_CR36","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcv.2005.09.001","volume":"35","author":"S Monnier-Benoit","year":"2006","unstructured":"Monnier-Benoit S, Dalstein V, Riethmuller D, Lalaoui N, Mougin C, Pretet JL (2006) Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions. J Clin Virol: Off Publ Pan Am Soc Clin Virol 35:270\u2013277","journal-title":"J Clin Virol: Off Publ Pan Am Soc Clin Virol"},{"key":"3_CR37","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/JCM.40.3.886-891.2002","volume":"40","author":"P Peitsaro","year":"2002","unstructured":"Peitsaro P, Johansson B, Syrjanen S (2002) Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 40:886\u2013891","journal-title":"J Clin Microbiol"},{"key":"3_CR38","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/JCM.01212-08","volume":"46","author":"M Saunier","year":"2008","unstructured":"Saunier M, Monnier-Benoit S, Mauny F, Dalstein V, Briolat J, Riethmuller D, Kantelip B, Schwarz E, Mougin C, Pretet JL (2008) Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J Clin Microbiol 46:3678\u20133685","journal-title":"J Clin Microbiol"},{"key":"3_CR39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-2407-12-160","volume":"12","author":"S Wang","year":"2012","unstructured":"Wang S, Wei H, Wang N, Zhang S, Zhang Y, Ruan Q, Jiang W, Xiao Q, Luan X, Qian X, Zhang L, Gao X, Sun X (2012) The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China. BMC Cancer 12:160","journal-title":"BMC Cancer"},{"key":"3_CR40","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.7314\/APJCP.2014.15.6.2869","volume":"15","author":"S Kahla","year":"2014","unstructured":"Kahla S, Kochbati L, Maalej M, Oueslati R (2014) Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma. Asian Pac J Cancer Prev 15:2869\u20132873","journal-title":"Asian Pac J Cancer Prev"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.seminoncol.2004.09.011","volume":"31","author":"ML Gillison","year":"2004","unstructured":"Gillison ML (2004) Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 31:744\u2013754","journal-title":"Semin Oncol"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","volume":"12","author":"HA Katki","year":"2011","unstructured":"Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S, Castle PE (2011) Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol 12:663\u2013672","journal-title":"Lancet Oncol"},{"key":"3_CR43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","volume":"11","author":"CR Leemans","year":"2011","unstructured":"Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9\u201322","journal-title":"Nat Rev Cancer"},{"key":"3_CR44","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/sj.bjc.6605944","volume":"103","author":"AM Hong","year":"2010","unstructured":"Hong AM, Dobbins TA, Lee CS, Jones D, Harnett GB, Armstrong BK, Clark JR, Milross CG, Kim J, O'Brien CJ, Rose BR (2010) Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer 103:1510\u20131517","journal-title":"Br J Cancer"},{"key":"3_CR45","doi-asserted-by":"crossref","first-page":"29s","DOI":"10.1177\/0022034514527969","volume":"93","author":"N Sathish","year":"2014","unstructured":"Sathish N, Wang X, Yuan Y (2014) Human Papillomavirus (HPV)-associated oral cancers and treatment strategies. J Dent Res 93:29s\u201336s","journal-title":"J Dent Res"},{"key":"3_CR46","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/ijc.28847","volume":"136","author":"H Mirghani","year":"2015","unstructured":"Mirghani H, Amen F, Blanchard P, Moreau F, Guigay J, Hartl DM, Lacau SGJ (2015) Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives. Int J Cancer 136:1494\u20131503","journal-title":"Int J Cancer"},{"key":"3_CR47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ijc.25671","volume":"129","author":"L Abramowitz","year":"2011","unstructured":"Abramowitz L, Jacquard AC, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, Aynaud O, Leocmach Y, Soubeyrand B, Dachez R, Riethmuller D, Mougin C, Pretet JL, Denis F (2011) Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer 129:433\u2013439","journal-title":"Int J Cancer"},{"key":"3_CR48","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/1471-2407-12-398","volume":"12","author":"MA Stanley","year":"2012","unstructured":"Stanley MA, Winder DM, Sterling JC, Goon PK (2012) HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues. BMC Cancer 12:398","journal-title":"BMC Cancer"},{"key":"3_CR49","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","volume":"124","author":"H Vuyst De","year":"2009","unstructured":"De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S (2009) Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 124:1626\u20131636","journal-title":"Int J Cancer"},{"key":"3_CR50","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ygyno.2005.02.012","volume":"97","author":"M Seters van","year":"2005","unstructured":"van Seters M, van Beurden M, de Craen AJ (2005) Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 97:645\u2013651","journal-title":"Gynecol Oncol"},{"key":"3_CR51","first-page":"923","volume":"194","author":"G Orth","year":"2010","unstructured":"Orth G (2010) Genetics and susceptibility to human papillomaviruses: epidermodysplasia verruciformis, a disease model. Bull Acad Natl Med 194:923\u2013940. discussion 941","journal-title":"Bull Acad Natl Med"},{"key":"3_CR52","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/MMBR.00033-08","volume":"73","author":"M Lazarczyk","year":"2009","unstructured":"Lazarczyk M, Cassonnet P, Pons C, Jacob Y, Favre M (2009) The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol Mol Biol Rev: MMBR 73:348\u2013370","journal-title":"Microbiol Mol Biol Rev: MMBR"},{"key":"3_CR53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.18553\/jmcp.2010.16.3.217","volume":"16","author":"EP Armstrong","year":"2010","unstructured":"Armstrong EP (2010) Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. J Manage Care Pharm: JMCP 16:217\u2013230","journal-title":"J Manage Care Pharm: JMCP"},{"key":"3_CR54","doi-asserted-by":"crossref","unstructured":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. New Engl J Med 356:1915\u20131927","DOI":"10.1056\/NEJMoa061741"},{"key":"3_CR55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","volume":"374","author":"J Paavonen","year":"2009","unstructured":"Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G (2009) Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet (London, England) 374:301\u2013314","journal-title":"Lancet (London, England)"},{"key":"3_CR56","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jadohealth.2013.09.018","volume":"53","author":"S Hariri","year":"2013","unstructured":"Hariri S, Markowitz LE, Dunne EF, Unger ER (2013) Population impact of HPV vaccines: summary of early evidence. J Adolesc Health: Off Publ Soc Adolesc Med 53:679\u2013682","journal-title":"J Adolesc Health: Off Publ Soc Adolesc Med"},{"key":"3_CR57","first-page":"f2032","volume":"346","author":"H Ali","year":"2013","unstructured":"Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Guy RJ (2013) Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ (Clin Res Ed) 346:f2032","journal-title":"BMJ (Clin Res Ed)"},{"key":"3_CR58","first-page":"300","volume":"64","author":"E Petrosky","year":"2015","unstructured":"Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE (2015) Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 64:300\u2013304","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3_CR59","doi-asserted-by":"crossref","first-page":"394595","DOI":"10.1155\/2014\/394595","volume":"2014","author":"A Nigam","year":"2014","unstructured":"Nigam A, Saxena P, Acharya AS, Mishra A, Batra S (2014) HPV Vaccination in India: Critical Appraisal. ISRN Obstet Gynecol 2014:394595","journal-title":"ISRN Obstet Gynecol"},{"key":"3_CR60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12929-014-0069-z","volume":"21","author":"A Tahamtan","year":"2014","unstructured":"Tahamtan A, Ghaemi A, Gorji A, Kalhor HR, Sajadian A, Tabarraei A, Moradi A, Atyabi F, Kelishadi M (2014) Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems. J Biomed Sci 21:69","journal-title":"J Biomed Sci"},{"key":"3_CR61","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s11606-016-3725-z","volume":"31","author":"M McNamara","year":"2016","unstructured":"McNamara M, Batur P, Walsh JM, Johnson KM (2016) HPV update: vaccination, screening, and associated disease. J Gen Intern Med 31:1360\u20131366","journal-title":"J Gen Intern Med"},{"key":"3_CR62","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/erm.09.64","volume":"9","author":"M Grce","year":"2009","unstructured":"Grce M (2009) Primary and secondary prevention of cervical cancer. Expert Rev Mol Diagn 9:851\u2013857","journal-title":"Expert Rev Mol Diagn"}],"container-title":["Advances in Experimental Medicine and Biology","Infectious Agents Associated Cancers: Epidemiology and Molecular Biology"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-5765-6_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T04:04:28Z","timestamp":1603166668000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-5765-6_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9789811057649","9789811057656"],"references-count":62,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-5765-6_3","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}